FDA Approved: GAMIFANT — Original Application (Swedish Orphan Biovitrum AB (publ))

View source ↗

Summary

FDA approved GAMIFANT (emapalumab-lzsg) in an original application for the treatment of primary hemophagocytic lymphohistiocytosis. It represents a first-in-cla…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophagocytic Lymphohistiocytosis

Drugs mentioned

• GAMIFANT (emapalumab-lzsg)

Snippet

ORIG AP for GAMIFANT (EMAPALUMAB-LZSG)